Clinical Trial Update: A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety of Mibavademab in adults and children with Generalized Lipodystrophy switching from Metreleptin; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Lipodystrophy

Drugs mentioned

• Mibavademab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Generalized Lipodystrophy | Phase 3 | Status: COMPLETED